01:37 PM, 31st Jan 2026
Astrazeneca Pharma India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 inter alia to consider and approve the unaudited financial results of the Company for the quarter ended December 31 2025.